Nephrology

Renal disease, dialysis, transplantation and electrolyte disorders.

Strive Health expands executive team to scale value-based kidney care

Strive Health adds three executives to support market operations, provider network performance and growth in value-based kidney care nationwide.

In a crossover trial, intravenous Pyr¹-apelin-13 did not meaningfully increase urine output in adults with experimentally induced hyponatremia.

Mary Dittrich’s profile and a new Medicare ACO transition article center kidney care, payment reform, and nephrology leadership.

Keith A. Bellovich’s leadership profile frames the policy stakes for kidney care as Medicare’s CKCC model sunsets and…

PHTI found eight virtual CKD platforms had no consistent impact on progression or spending, with only a small…

Human kidney organoids showed MANF can clear mutant uromodulin in ADTKD-UMOD, pointing to a potential strategy for a…

Estuary Biotherapeutics raised $103 million to advance two AAV gene therapies for ADPKD, with one program slated for…

A pilot study found telehealth-supported exercise planning was feasible and acceptable for adolescents with chronic kidney disease, with…

Cochrane’s chronic conditions collection centers on blood pressure targets in chronic renal disease and other reviews tied to…

Transcriptomic analysis of CKD and ESRD points to EPB42, KLF1, and H3F3A as stage-linked biomarkers with possible diagnostic…

Nephrology

Renal disease, dialysis, transplantation and electrolyte disorders.

In Brief The 5-minute rounds